Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Appointed director

HOOKIPA Pharma Inc. (HOOK) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 4 Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 7,000 shares @ $0.725, valued at $5.1k
08/17/2023 4 Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 8,000 shares @ $0.714, valued at $5.7k
07/11/2023 4 Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 5,000 shares @ $0.81, valued at $4.1k
Bought 5,000 shares @ $0.8284, valued at $4.1k
07/07/2023 4 Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 5,000 shares @ $0.89, valued at $4.5k
07/05/2023 4 Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 5,000 shares @ $0.8911, valued at $4.5k
07/03/2023 4 Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Bought 12,000 shares @ $0.88, valued at $10.6k
06/09/2023 4 Peters Malte (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 52,000 options to buy @ $1.01, valued at $52.5k
06/09/2023 4 Reilly Timothy P. (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 26,000 options to buy @ $1.01, valued at $26.3k
06/09/2023 4 O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 26,000 options to buy @ $1.01, valued at $26.3k
06/09/2023 4 van de Winkel Jan (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 52,000 options to buy @ $1.01, valued at $52.5k
06/09/2023 4 Kaufman David Ross (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 26,000 options to buy @ $1.01, valued at $26.3k
06/09/2023 4 Coelho Mary Theresa (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 52,000 options to buy @ $1.01, valued at $52.5k
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/04/2023 3 Coelho Mary Theresa (Director) has filed a Form 3 on HOOKIPA Pharma Inc.
07/01/2022 4 van de Winkel Jan (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 40,000 options to buy @ $1.63, valued at $65.2k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Orlinger Klaus (Chief Scientific Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 48,350 options to buy @ $1.66, valued at $80.3k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Necina Roman (Chief Technology Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 48,350 options to buy @ $1.66, valued at $80.3k
07/01/2022 4 Matushansky Igor (Chief Medical Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 92,950 options to buy @ $1.66, valued at $154.3k
07/01/2022 4 Kelly Michael Aaron (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 20,000 options to buy @ $1.63, valued at $32.6k
07/01/2022 4 Kaufman David Ross (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 20,000 options to buy @ $1.63, valued at $32.6k
07/01/2022 4 Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 92,950 options to buy @ $1.66, valued at $154.3k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2022 4 Orlinger Klaus (Chief Scientific Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 48,350 options to buy @ $1.66, valued at $80.3k
04/20/2022 4 Necina Roman (Chief Technology Officer) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns: Granted 48,350 options to buy @ $1.66, valued at $80.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy